GT Apeiron Therapeutics Company
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational medicines by harnessing the power of artificial intelligence, aiming to drastically increase efficiency throughout the drug discovery process.
Technology:
Computational Drug Design & Virtual Screening
Industry:
BioPharma AI
Funding Status:
private
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2019-01-01 00:00:00